The Controversy: Steroids in sepsis/septic shock
|When||September 13, 2018, 1215 to 1300|
Recently, there have been several potentially practice changing publications exploring the use of steroids in the treatment of septic shock. Join us as we review the background literature and these recent large trials.
In this webinar, participants will have the chance to:
- Review the scientific rationale behind the use of steroids in sepsis
- Discuss “Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.” Venkatesh, et al. 2018. DOI: 0.1056/NEJMoa1705835
- “Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.” Annane, et al. for the CRICS-TRIFFERSEP Network. 2018.
Who Should Attend?
- Physicians caring for patients in medical, surgical, ED or ICU units
- Nurses, allied health and lab techs who are interested in sepsis improvement
- Clinical educators
- Quality improvement and patient safety
Dr. Dave Sweet completed fellowship positions in Emergency Medicine and Critical Care Medicine at the University of British Columbia. He currently holds attending positions in Emergency Medicine and Critical Care Medicine at Vancouver General Hospital and is the education director for the ICU at Vancouver General Hospital. He is the provincial clinical lead for sepsis quality improvement with the BC Patient Safety and Quality Council. In 2015 Dr. Sweet received the Global Sepsis award for the recent advances in sepsis care in British Columbia.
Join the BC Sepsis Network: email@example.com